On June 12, WUXI BIO (02269) spent 99.7766 million Hong Kong dollars to repurchase 3.269 million shares.
WuXi Biologics (02269) announced that it would spend 99.7766 million Hong Kong dollars to repurchase 3.269 million shares on June 12, 2026.
Wuxi Bio (02269) announced on June 12, 2026 that it will repurchase 3.269 million shares at a cost of 99.77 million Hong Kong dollars.
On June 12, 2026, the company issued 21,000 shares in accordance with the pre-emptive rights plan adopted by the company on January 5, 2016 (revised on August 10, 2016).
Related Articles
US Stock Market Move | Some chip stocks are performing well, with Qualcomm (QCOM.US) rising over 5%.
.png)
US Stock Market Move | Most concept stocks in the field of optical communication are rising, with Coherent (COHR.US) increasing by more than 7%.
New stock news | Coming soon to the market! Zhenjiankang Medical successfully passed the hearing and secured the first stock of Siasun Robot & Automation, focusing on puncture surgery!
US Stock Market Move | Some chip stocks are performing well, with Qualcomm (QCOM.US) rising over 5%.
US Stock Market Move | Most concept stocks in the field of optical communication are rising, with Coherent (COHR.US) increasing by more than 7%.
New stock news | Coming soon to the market! Zhenjiankang Medical successfully passed the hearing and secured the first stock of Siasun Robot & Automation, focusing on puncture surgery!
RECOMMEND
